Martin Wilson - General Counsel at ROCKET PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel
Issuer Symbol
RCKT, RCKTW on Nasdaq
All Insider Reports
All Insider Reports

Martin Wilson - trading volume in the past year for ROCKET PHARMACEUTICALS, INC.

Holdings reported by Martin Wilson for ROCKET PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 134,642 $2,025,016 $15.04 11 Feb 2025 Direct Common Stock
Common Stock 383,816 $1,144,923 $2.98 18 Nov 2025 Direct

Transactions reported by Martin Wilson for ROCKET PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.